Serum biomarkers and changes in clinical/MRI evidence of golimumab-treated patients with ankylosing spondylitis: results of the randomized, placebo-controlled GO-RAISE study

Table 1 Correlations between baseline serum biomarker levels and baseline ASDAS

	Baseline ASDAS Spearman correlation coefficient (r _s)
Baseline serum biomarker	Patients (n)	r _s	Bonferroni-adjusted p value
IL-6	132	0.59	0.000
ICAM-1	139	0.39	0.011
C3	98	0.53	0.000
CRP	98	0.66	0.000
Haptoglobin	98	0.46	0.010
Serum amyloid-P	98	0.50	0.001

Abbreviations: ASDAS Ankylosing Spondylitis Disease Activity Score employing C-reactive protein, CRP C-reactive protein, C3 Complement component 3, ICAM-1 Intracellular adhesion molecule-1, IL Interleukin

ISSN: 1478-6362